Published in Ann Ital Chir on January 01, 1978
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol (1993) 2.23
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer (1993) 1.44
Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines. J Immunother (2001) 1.42
Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis (2011) 1.22
Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 1.18
Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol (1995) 1.17
New agents for sedation in the intensive care unit. Crit Care Clin (2001) 1.17
The "vanishing counting bead" phenomenon: effect on absolute CD34+ cell counting in phosphate-buffered saline-diluted leukapheresis samples. Cytometry (2001) 1.11
Validity and reproducibility of alcohol consumption in Italy. Int J Epidemiol (1996) 1.08
CA 72-4 serum marker--a new tool in the management of carcinoma patients. Cancer Invest (1995) 1.05
Influence of food groups and food diversity on breast cancer risk in Italy. Int J Cancer (1995) 1.03
Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg (2000) 1.02
Dietary and familial determinants of 10-year survival among patients with gastric carcinoma. Cancer (2000) 1.00
Squamous and adenosquamous cell carcinomas of the gallbladder. J Exp Clin Cancer Res (2005) 0.99
P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology (2002) 0.99
Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer (1989) 0.96
Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade. J Neurochem (2008) 0.94
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience (2001) 0.90
Erectile dysfunction in men with obstructive sleep apnea: an early sign of nerve involvement. Sleep (2000) 0.90
Integrin Beta-4 expression in colorectal-cancer. Int J Oncol (1994) 0.90
Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J Am Coll Surg (2000) 0.90
Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol (2001) 0.89
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. Int J Cancer (1997) 0.89
Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort. Eur J Clin Nutr (2009) 0.87
Unusual presentation of leptospirosis in the late stage of pregnancy. Minerva Anestesiol (2007) 0.87
Plasma levels of antioxidant vitamins and cholesterol in a large population sample in central-northern Italy. Eur J Nutr (1999) 0.85
Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines. Leuk Res (2007) 0.85
Sources of macro- and micronutrients in Italian women: results from a food frequency questionnaire for cancer studies. Eur J Cancer Prev (1997) 0.84
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients. Anticancer Res (1996) 0.83
[Cytomegalovirus-induced protein-losing gastropathy: a case report]. Pediatr Med Chir (2006) 0.83
Transmission of HTLV-III infection by heterosexual contact. Lancet (1985) 0.83
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study. J Immunother (1999) 0.83
Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology (2000) 0.82
Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma. J Exp Clin Cancer Res (2003) 0.82
Influence of ventilator settings on patient-ventilator synchrony during pressure support ventilation with different interfaces. Intensive Care Med (2010) 0.82
TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer (1993) 0.82
[Laparoscopic intraperitoneal antiblastic hyperthermic chemoperfusion in the treatment of refractory neoplastic ascites. Preliminary results]. Suppl Tumori (2006) 0.81
Cerebellar lesion up-regulates P2X1 and P2X2 purinergic receptors in precerebellar nuclei. Neuroscience (2002) 0.81
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei. J Exp Clin Cancer Res (2003) 0.81
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma. J Exp Clin Cancer Res (2003) 0.81
Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Cancer Res (1996) 0.81
The application of hyperthermia in regional chemotherapy. Semin Surg Oncol (1998) 0.80
Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (2009) 0.80
[Family planning and reproductive behavior in Islamic countries in the Mediterranean area]. Genus (1994) 0.79
Hypoalbuminaemia and propofol pharmacokinetics. Br J Anaesth (2005) 0.79
Acute severe arterial hypertension: therapeutic options. Curr Drug Targets (2009) 0.79
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. Transplant Proc (2009) 0.79
Influence of some covariates on the reproducibility of an Italian semi-quantitative food frequency questionnaire. Eur J Cancer Prev (1995) 0.79
Contributions of specific foods to absolute intake and between-person variation of nutrient consumption. J Am Diet Assoc (1991) 0.79
[Alcohol and smoking. The risk factors for the oral cavity]. Minerva Stomatol (1996) 0.79
Use of IgG Avidity test in case definitions of toxoplasmosis in pregnancy. New Microbiol (2004) 0.78
[Serum levels of tobramycin during selective decontamination of the gastrointestinal tract]. Minerva Anestesiol (1988) 0.78
Epidemiological aspects of HTLV-III infection in Italy. Eur J Epidemiol (1985) 0.78
Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha. J Exp Clin Cancer Res (2004) 0.78
Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS (1993) 0.78
Nasal obstruction improvement induced by topical furosemide in subjects affected by perennial nonallergic rhinitis. Am J Rhinol (1998) 0.77
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H. Leukemia (2004) 0.77
The best timing for defibrillation in shockable cardiac arrest. Minerva Anestesiol (2012) 0.77
The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities. World J Surg (1988) 0.77
1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death. Transl Psychiatry (2013) 0.77
Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone Marrow Transplant (2006) 0.77
The role of multiploidy as unfavorable prognostic variable in colorectal cancer. Anticancer Res (1998) 0.76
Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in Italy. Am J Epidemiol (1986) 0.76
Clinical modulation of epirubicin resistance by lonidamine in patients with advanced soft-tissue sarcomas. Int J Oncol (1995) 0.76
Immunological responses of patients with recurrent herpes genitalis. Diagn Immunol (1986) 0.76
Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. J Surg Oncol Suppl (1991) 0.76
Topographic sector-by-sector analysis of the optic nerve head by HRT and correlation with frank glaucoma perimetric indices. Acta Ophthalmol Scand Suppl (2000) 0.76
Nerve-sparing surgery in 302 resectable rectosigmoid cancer patients: genitourinary morbidity and 10-year survival. Dis Colon Rectum (1994) 0.76
Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma. Anticancer Res (1994) 0.75
Increased IL-6 gene expression and production in patients with common variable immunodeficiency. Clin Exp Immunol (1993) 0.75
[Oral hygiene in subjects treated with diphenylhydantoin: effects of a professional program]. Prev Assist Dent (1991) 0.75
Pre-emptive or preventive analgesia? Minerva Anestesiol (2013) 0.75
[A case of mixed lithium and phenothiazine poisoning with a fatal outcome]. Recenti Prog Med (1984) 0.75
TNFa-based isolated hyperthermic limb perfusion (HILP) in the treatment of limb recurrent melanoma: update 16 years after its first clinical application. J Chemother (2004) 0.75
[Surgical treatment of obesity: our experience]. G Chir (1997) 0.75
TAG-72 expression and its role in the biological evaluation of human colorectal cancer. Anticancer Res (1996) 0.75
[Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs]. Suppl Tumori (2006) 0.75
[Laparoscopic treatment of neoplasms of the body end tail of the pancreas: technical notes]. Suppl Tumori (2006) 0.75
Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study. J Exp Clin Cancer Res (2003) 0.75
Comparative evaluation of different helmets on patient-ventilator interaction during noninvasive ventilation. Intensive Care Med (2008) 0.75
Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma. World J Surg (1995) 0.75
Should some Italian ICU beds be lowered from high to low level-of-care beds due to inadequate human or instrumental resources? Minerva Anestesiol (2007) 0.75
Liposomal doxorubicin in the perfusional treatment of advanced soft tissue limb sarcoma. J Chemother (2004) 0.75
A year in Review in Minerva Anestesiologica, 2009. Minerva Anestesiol (2010) 0.75
Hyperthermic antiblastic perfusion in the treatment of locoregional spreading limb melanoma. J Exp Clin Cancer Res (2003) 0.75
Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences. Melanoma Res (1994) 0.75
[Gastrointestinal stromal tumors (GIST). Update and indications for treatment: our experience]. Suppl Tumori (2006) 0.75
[Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase]. Tumori (2003) 0.75
[Hyperthermic-antiblastic perfusion in the treatment of tumor of the extremities]. Suppl Tumori (2002) 0.75
Chronic middle ear effusion after prolonged intubation. Anaesthesia (1994) 0.75
[Integrated treatment of peritoneal carcinomatosis: preliminary experience]. Suppl Tumori (2006) 0.75